Home › Atherosclerosis › North Carolina › Winston-Salem
Atherosclerosis clinical trials in Winston-Salem, NC
5 studies for Atherosclerosis are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Brookview Hills Research Associates Llc, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- Javara Inc. - Wake Forest University Health Sciences, Winston-Salem
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Winston-Salem
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RecruitingPhase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
RecruitingPhase 2
- Wake Forest University Health Sciences, Winston-Salem
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Las Vegas, NV7 studies
- Miami, FL7 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Dallas, TX7 studies
- Los Angeles, CA6 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.